ABTS Abits Group Inc. - Fundamental Analysis

BEARISH

ABTS Stock | Fundamental Analysis & Investment Insights

NASDAQ • Financial Services • Capital Markets

Current Price Live

$2.79

52W High

$10.86

52W Low

$0.25

Overview AI Snowflake Price Valuation Profitability Growth Health Peers

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Feb 14, 2026

Market cap

$6.61M

P/E

N/A

ROE

-8.7%

Profit margin

-11.9%

Debt/Equity

0.23

Dividend yield

N/A

AI Analysis

Confidence Score

85%

Analysis Accuracy

ABTS exhibits weak financial health with a Piotroski F-Score of 3/9, indicating significant operational and financial distress. The company reports negative profitability metrics, including a -11.86% profit margin and -8.71% ROE, despite a modest 6% revenue growth. Its extremely low current and quick ratios (0.18) signal severe liquidity risk, and the absence of an Altman Z-Score raises bankruptcy concerns. While the stock trades at a discount to book value (Price/Book = 0.68), this is not indicative of value given the underlying deterioration in earnings and cash flow. The recent sharp decline in price (down 49.5% in one month) reflects deteriorating market sentiment.

Key Strengths

Gross margin of 52.33% suggests strong pricing power or cost control in core operations

Price/Book ratio of 0.68 indicates trading at a discount to tangible book value

Revenue growth of 6.00% YoY shows some top-line expansion despite profitability issues

Debt/Equity ratio of 0.23 is relatively low, indicating conservative leverage

Insider sentiment at 40/100 suggests minimal selling pressure, though not strongly supportive

Key Risks

Piotroski F-Score of 3/9 signals poor financial health and operational inefficiency

Negative operating margin (-39.51%) and ROE (-8.71%) indicate sustained losses

Current and quick ratios of 0.18 imply severe liquidity constraints and inability to meet short-term obligations

No available data on cash flow, free cash flow, or debt levels raises transparency concerns

Stock has experienced extreme volatility, including a 553.4% 1-year return followed by a 49.5% drop in one month, indicating speculative and unstable pricing

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall

Weak

Value

Future

Past

Health

Dividend

AI Verdict

Weak

Key drivers: Low Piotroski F-Score (3/9), Negative profitability and cash flow, Severe liquidity issues (current ratio 0.18), No analyst coverage or target price, High price volatility and recent sharp decline

Confidence

88%

Value

55/100

While P/B and P/S ratios suggest potential value, the absence of profitability and cash flow renders these metrics unreliable as standalone indicators.

Positives

Price/Book of 0.68 suggests trading below book value
Price/Sales of 0.90 is below 1.0, indicating potential undervaluation on revenue

Watchpoints

No Graham Number or intrinsic value estimate available
Negative earnings and cash flow undermine fundamental valuation
Lack of reliable financial data (e.g., FCF, debt) limits valuation accuracy

Future

40/100

Growth is limited by persistent losses and poor operating efficiency; future upside is speculative without improvement in margins or cash flow.

Positives

6.00% YoY revenue growth indicates some top-line momentum
Gross margin of 52.33% is strong and could support future margin expansion

Watchpoints

No earnings growth data available, and profitability is deeply negative
No forward P/E or PEG ratio to assess growth expectations
Lack of analyst coverage prevents insight into future earnings projections

Past

25/100

Historical returns are misleading due to extreme volatility; the stock appears to be in a speculative cycle rather than a sustainable trend.

Positives

5-year return of +3.7% shows long-term resilience
3-year return of +147.6% indicates strong historical performance

Watchpoints

1-year return of +553.4% followed by a 49.5% drop in one month suggests extreme volatility and speculative bubble behavior
52-week high of $10.86 vs. current price of $2.79 reflects a 74% correction
Recent price decline indicates loss of momentum and investor confidence

Health

20/100

Despite low leverage, the company's core operations are unprofitable and liquidity is severely constrained, making the financial health weak.

Positives

Debt/Equity ratio of 0.23 is low, indicating conservative capital structure
No Altman Z-Score available, but the low leverage is a positive

Watchpoints

Piotroski F-Score of 3/9 is critically low, indicating financial distress
Current and quick ratios of 0.18 are dangerously low, signaling liquidity crisis
Negative ROE, ROA, and operating margin reflect poor operational performance
No available data on cash flow or debt levels limits health assessment

Dividend

0/100

No dividend is paid, and the company's losses preclude any possibility of future payouts.

Positives

No standout positives identified.

Watchpoints

Dividend yield and payout ratio are not available
Dividend strength is 0/100, indicating no dividend payments
Negative earnings make dividend sustainability impossible

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price

$2.79

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ABTS and closest competitors.

Updated 2026-02-13

Company	5Y	3Y	1Y	6M	1M	1W
ABTS Abits Group Inc. Primary	+3.7%	+147.6%	+553.4%	-33.7%	-49.5%	-10.3%
BNBX BNB Plus Corp. Peer	-100.0%	-100.0%	-98.9%	-68.5%	-31.5%	-4.8%
ANY Sphere 3D Corp. Peer	-99.3%	-94.1%	-77.2%	-63.6%	-47.4%	-26.6%
ARBK Argo Blockchain plc Peer	-99.9%	-99.0%	-96.0%	-94.1%	+16.5%	-6.9%
BHV BlackRock Virginia Municipal Bond Trust Peer	-20.3%	+1.4%	+2.7%	+3.0%	+0.3%	-1.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

N/A

0.68

0.9

1.19

5.63

$6.61M

Profitability

Profit margins and return metrics

Profit Margin -11.86%

Operating Margin -39.51%

Gross Margin 52.33%

ROE -8.71%

ROA -8.13%

Growth

Revenue and earnings growth rates

Revenue Growth +6.0%

Earnings Growth N/A

Q/Q Revenue Growth N/A

Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity

0.23

Low debt

Current Ratio

0.18

Weak

Quick Ratio

0.18

Poor

Cash/Share

$0.04

Financial Services Sector Comparison

Comparing ABTS against 208 companies in the Financial Services sector (5 bullish, 111 neutral, 92 bearish)

Return on Equity (ROE)

-8.71%

This Stock

-7.57%

Sector Avg

+15.0% (Excellent)

Profit Margin

-11.86%

This Stock

83.86%

Sector Avg

-114.1% (Weaker)

Debt to Equity

0.23

This Stock

1.51

Sector Avg

-84.7% (Less Debt)

Revenue Growth

6.0%

This Stock

30.29%

Sector Avg

-80.2% (Slower)

Current Ratio

0.18

This Stock

3.78

Sector Avg

-95.3% (Weaker)

Similar Companies

Peer comparison within the same industry

Company	AI Rating	Market Cap	P/E	ROE	Profit Margin	Price
ABTS Abits Group Inc.	BEARISH	$6.61M	-	-8.7%	-11.9%	$2.79
BNBX BNB Plus Corp.	BEARISH	$6.94M	-	-274.2%	-%	$1.59
ANY Sphere 3D Corp.	BEARISH	$6.04M	-	-52.9%	-167.5%	$0.18
ARBK Argo Blockchain plc	BEARISH	$1.46M	-	-%	-106.8%	$4.37
BHV BlackRock Virginia...	BEARISH	$16.69M	-	-8.0%	-106.1%	$10.51

Past News Coverage

Recent headlines mentioning ABTS from our newsroom.

Newest → oldest

Back to All Stocks

TradingGPT V1 Copilot

Fundamentals • Valuation • Risk

Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends